Biomaterials and devices have been used in a variety of applications ranging from disposable extracorporeal devices and soft and hard tissue augmentation, to total artificial internal organs. However, there are risks and failures in each application which are a result of undesirable biological interactions. This article deals with various biological interactions in each category of implants and devices used in medical applications.
Get full access to this article
View all access options for this article.
References
1.
Ames, B.N. and L.S. Gold.1990. "Too Many Rodent Carcinogens: Mitogenesis Increases Mutagenesis," Science, 249:970-971.
2.
Ashby, J. and R.S. Morrod.1991. "Detection of Human Carcinogens," Nature, 352:185-186.
3.
Chandran, K.B., R. Fatemi and R. Schoephoerster et al. 1989. "In vitro Comparison of Velocity Profiles and Turbulent Shear Distal to Polyurethane Trileaflet and Pericardial Prosthetic Valves;' Artificial Organs, 13(2):148-154.
4.
Chenoweth, D.E.1988. "Complement Activation Produced by Biomaterials," Artificial Organs, 12(6):502-504.
5.
Fehrenbacher, J.W., W. Bowers and R. Strate et al. 1981. "Angiosarcoma of the Aorta Associated with a Dacron Graft," Ann. Thoracic Surg., 32:297-301.
Hausner, R.J., F.J. Schoen and K.K. Pierson.1978. "Foreign Body Reaction to Silicone Gel in Axillary Lymph Nodes after an Augmentation Mammaplasty," Plast. Reconstr. Surg., 62:381-384.
8.
Hopes, J.C., M.T. Edgerson, Jr. and W. Shelley.1967. "Organic Synthetics for Augmentation Mammaplasty: The Relations to Breast Cancer," Plast. Reconstr. Surg., 39:263-270.
9.
Ikeda, T., S. Kohjiya, S. Yamashita, H. Fukumura and S. Yoshikawa.1988. "Activation of the Complement System in Blood on the Surface of Segmented Polyurethane Urea Having Good Blood Compatibility ," Polymer J., 20(3):273-276.
10.
Mohr, W. and Kirkapatrick.1983. "Biocompatibility of Polymers," in Alloplastic Ligament Replacement. Bern, Stuttgart : Hans Huber Publishing, p. 18.
11.
O'Connell, T.X., H.J. Fee and A. Golding.1976. "Sarcoma Associated with Dacron Prosthetic Material-Case Report and Review of Literature," J. Thoracic CardiovascularSurg., 72:94-96.
12.
Oppenheimer, B.S., E.T. Oppenheimer and T. Danishefsky et al. 1955. "Further Studies of Polymers as Carcinogenic Agent in Animals," Cancer Res., 15:333-340.
13.
Payne, M.S. and T.A. Horbett.1987. "Complement Activation by Hydroxy Ethylmethacrylate-Ethylmethacrylate Copolymers," J. Biomedical Mat. Res., 21:843-859.
14.
Rames, A. and D.F. Willioms.1991. "Neutrophil Polarization and Immuno Electrophoresis Assays in the Study of Complement Activation by Biomaterials ," Biomaterials, 12:607-613.
15.
Schoen, F.J.1991. "Biomaterial Science, Medical Devices and Artificial Organs: Synergistic Interactions for the 1990s," Trans. Am. Soc. Artif. Int. Organs, 37:44-48.
